REG Results Announcement 1H FY26

Open PDF
Stock Regis Healthcare Ltd (REG.ASX)
Release Time 23 Feb 2026, 8:44 a.m.
Price Sensitive Yes
 Regis Healthcare Reports Improved H1 FY26 Results
Key Points
  • Revenue from services up 18% to $667.7 million
  • Underlying EBITDA up 4% to $70.6 million
  • Net operating cash flow up 40% to $291.7 million
  • Completed acquisitions of Rockpool and OC Health
Full Summary

Regis Healthcare Limited (ASX: REG) reported its H1 FY26 financial results, highlighting improved operating performance and strong cash flow generation. Revenue from services increased by 18% to $667.7 million, driven by higher AN-ACC pricing, improved occupancy, and recent acquisitions. Underlying EBITDA rose 4% to $70.6 million, while underlying NPAT was up 0.1% to $29.7 million. Net operating cash flow increased 40% to $291.7 million, including a net refundable accommodation deposits (RADs) cash inflow of $178.5 million. The company completed the acquisitions of Rockpool (four homes, 600 beds) and OC Health (two homes, 230 beds), and continued to progress its greenfield development pipeline. Regis also announced an interim dividend of 9.0 cents per share. The company remains well-positioned to benefit from structural tailwinds, with a target of reaching 10,000 quality beds by FY28 through a combination of greenfield developments and future acquisitions. Regis expects FY26 underlying EBITDA to be in the range of $130 million to $135 million.

Guidance

Regis expects FY26 underlying EBITDA to be in the range of $130 million to $135 million.

Outlook

Regis remains well positioned to benefit from structural tailwinds, including recent funding reforms, favorable demographic trends, and improved workforce availability. The company has set a target of reaching 10,000 quality beds by FY28, which will be achieved through a combination of greenfield developments and future acquisitions.